November 8, 2024
Share on PinterestSeven out of 10 states that had abortion on the ballot during the 2024 presidential election voted to expand abortion access. Kent Nishimura/Getty Images […]
November 8, 2024
The US Food and Drug Administration (FDA) has approved obecabtagene autoleucel, or obe-cel (AUTO1, Autolus Therapeutics) for the treatment of relapsed or refractory adult B-cell acute […]
November 8, 2024
[11-08-2024] The Food and Drug Administration is advising consumers not to purchase or use VITAFER-L Gold 10ml, a product promoted for energy and sexual enhancement on […]
November 8, 2024
[11-08-2024] The Food and Drug Administration is advising consumers not to purchase or use VITAFER-L Gold 20ml, a product promoted for energy and sexual enhancement on […]
November 8, 2024
[11-08-2024] The Food and Drug Administration is advising consumers not to purchase or use VITAFER-L Gold 500ml, a product promoted for energy and sexual enhancement on […]
November 8, 2024
On November 8, 2024, the Food and Drug Administration approved obecabtagene autoleucel (Aucatzyl, Autolus Inc.), a CD19-directed genetically modified autologous T cell immunotherapy, for adults with […]
November 8, 2024
For Immediate Release: November 08, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the […]
November 8, 2024
COMMITTEE’S OFFICIAL DESIGNATION Drug Safety and Risk Management Advisory Committee AUTHORITY The Drug Safety and Risk Management Advisory Committee (the Committee) is established under 15 U.S.C. […]
November 8, 2024
Recruitment and hiring events No matter your field of study or professional background, you can be a part of the workforce that’s protecting the health and […]